Accustem Sciences ACUT
OTC ACUT
$0.14 +0.00 (+0.00%)
At close: Oct 1, 2026 · 4:00 PM EDT

Accustem Sciences (ACUT) Return on Sales [ROS] (2026)

Updated

Accustem Sciences (ACUT) reported Return on Sales [ROS] of -256.68% for Q2 2026.

Analysis

Accustem Sciences (ACUT) Return on Sales [ROS] (2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 HCA Healthcare 93.08 Bn 92.52 Bn - 15.29%
2 Natera 58.93 Bn 54.61 Bn 485.19 Mn -10.07%
3 Quest Diagnostics 25.75 Bn 24.18 Bn 1.03 Bn 15.08%
4 Labcorp Holdings 24.96 Bn 22.73 Bn 1.11 Bn 12.10%
5 Guardant Health 23.76 Bn 19.82 Bn 219.03 Mn -38.55%
6 Tenet Healthcare 20.83 Bn 11.98 Bn - 26.67%
7 Tempus AI 13.43 Bn 10.46 Bn 246.50 Mn -19.85%
8 BrightSpring Health Services 11.90 Bn 10.24 Bn 492.75 Mn 3.37%
9 Encompass Health 11.82 Bn 12.29 Bn - 18.43%
10 Accustem Sciences 2.25 Mn 2.20 Mn - -256.68%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -256.68%
API Access

Accustem Sciences Return on Sales [ROS] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=ACUT&period=max&api_key=YOUR_API_KEY